Abstract: The invention concerns in particular novel peptides and polypeptides comprising at least the following sequence in amino acids: -W-S-A1-C-S-A2-C-G- in which A1 and A2 are amino acid sequences comprising 1 to 5 amino acids, useful as medicines in therapeutic treatments involving the regeneration of the nervous system cells, for treating neuroblastomas, and also useful as additives in the culture of nervous cells.
Type:
Grant
Filed:
July 16, 1998
Date of Patent:
February 7, 2006
Assignees:
NUCLEICA, Institut National de la Sante et de la Recherche Medicale (INSERM)